{
    "clinical_study": {
        "@rank": "65567", 
        "arm_group": [
            {
                "arm_group_label": "Normal diet", 
                "arm_group_type": "No Intervention", 
                "description": "Two weeks of unaltered diet"
            }, 
            {
                "arm_group_label": "Low omega-6/high omega-3 diet", 
                "arm_group_type": "Experimental", 
                "description": "Restricting daily intake of omega-6 fatty acids to less than 4 grams and increasing omega-3 fatty acids to 3 grams"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this trial is to test the hypothesis that a treatment diet low in omega-6\n      fatty acids and high in omega-3 fatty acids can cause improvement in asthma symptoms, nasal\n      symptoms, and pulmonary function in patients with aspirin-exacerbated respiratory disease\n      (AERD)."
        }, 
        "brief_title": "High Omega-3/Low Omega-6 Treatment Diet for Aspirin-exacerbated Respiratory Disease (AERD)", 
        "condition": [
            "ASA Triad", 
            "Asthma, Nasal Polyps, And Aspirin Intolerance"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Nasal Polyps", 
                "Respiration Disorders", 
                "Respiratory Tract Diseases"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  History of physician-diagnosed asthma\n\n          -  History of nasal polyposis\n\n          -  History of at least two reactions to oral aspirin or other nonselective\n             cyclooxygenase inhibitor with features of lower airway involvement (cough, chest\n             tightness, wheezing, dyspnea), or diagnosis of AERD via a physician-conducted\n             challenge to aspirin\n\n          -  Age between 18 and 70 years\n\n        Exclusion Criteria:\n\n          -  Current smoking, defined as daily tobacco smoking in the last 6 months and at least\n             one instance of tobacco smoking in the last 3 months.\n\n          -  Current pregnancy or breastfeeding\n\n          -  BMI <20\n\n          -  History of allergy to fish or any unwillingness to eat fish as a regular part of the\n             diet\n\n          -  Use of Zyflo (zileuton) in the last two weeks\n\n          -  Presence of an implantable cardioverter-defibrillator\n\n          -  Use of oral steroids in the last two weeks\n\n          -  Participation in any other clinical trial in the last month\n\n          -  Any use of nonsteroidal antiinflammatory drugs (NSAIDs) or any drug that inhibits the\n             cyclooxygenase enzyme during the course of the study"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "10", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 14, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02064738", 
            "org_study_id": "2013-P002683"
        }, 
        "intervention": {
            "arm_group_label": "Low omega-6/high omega-3 diet", 
            "intervention_name": "Restricting daily intake of omega-6 fatty acids to less than 4 grams and increasing omega-3 fatty acids to 3 grams", 
            "intervention_type": "Behavioral"
        }, 
        "intervention_browse": {
            "mesh_term": "Aspirin"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Omega-3 fatty acids", 
            "Omega-6 fatty acids", 
            "aspirin exacerbated respiratory disease", 
            "AERD", 
            "Samter's Triad", 
            "nasal polyp", 
            "aspirin", 
            "diet", 
            "leukotriene"
        ], 
        "lastchanged_date": "May 22, 2014", 
        "link": {
            "description": "Brigham and Women's Hospital AERD website", 
            "url": "http://aerd.partners.org"
        }, 
        "location": {
            "contact": {
                "email": "tlaidlaw@partners.org", 
                "last_name": "Tanya M Laidlaw, MD", 
                "phone": "617-525-1034"
            }, 
            "facility": {
                "address": {
                    "city": "Boston", 
                    "country": "United States", 
                    "state": "Massachusetts", 
                    "zip": "02115"
                }, 
                "name": "Brigham and Women's Hospital"
            }, 
            "investigator": [
                {
                    "last_name": "Tanya M Laidlaw, MD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Katherine N Cahill, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Paige Wickner, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Juan Carlos Cardet, MD", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Pilot Study of the Effectiveness of a High Omega-3/Low Omega-6 Treatment Diet for Treating Aspirin-exacerbated Respiratory Disease", 
        "other_outcome": [
            {
                "measure": "Change in urinary prostaglandin D2 level", 
                "safety_issue": "No", 
                "time_frame": "2 weeks and 4 weeks"
            }, 
            {
                "measure": "Change in blood eosinophil count", 
                "safety_issue": "No", 
                "time_frame": "2 weeks and 4 weeks"
            }, 
            {
                "measure": "Change in platelet-leukocyte aggregates", 
                "safety_issue": "No", 
                "time_frame": "2 weeks and 4 weeks"
            }
        ], 
        "overall_contact": {
            "email": "tlaidlaw@partners.org", 
            "last_name": "Tanya M Laidlaw, MD", 
            "phone": "6175251034"
        }, 
        "overall_contact_backup": {
            "email": "cjohns1@partners.org", 
            "last_name": "Christina Johns", 
            "phone": "6175251267"
        }, 
        "overall_official": {
            "affiliation": "Brigham and Women's Hospital", 
            "last_name": "Tanya M Laidlaw, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "Change in urinary leukotriene E4 levels", 
                "safety_issue": "No", 
                "time_frame": "2 weeks and 4 weeks"
            }, 
            {
                "measure": "Change in serum leukotriene B4 levels", 
                "safety_issue": "No", 
                "time_frame": "2 weeks and 4 weeks"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02064738"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Brigham and Women's Hospital", 
            "investigator_full_name": "Tanya Laidlaw, MD", 
            "investigator_title": "Assistant Professor of Medicine, Harvard Medical School", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Change in asthma control questionnaire score", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 2 weeks, and 4 weeks"
            }, 
            {
                "measure": "Change in Sino-Nasal Outcome Test-22 (SNOT-22) score", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 2 weeks, and 4 weeks"
            }, 
            {
                "measure": "Change in forced expiratory volume in one second  (FEV1), forced vital capacity   (FVC), and FEV1/FVC", 
                "safety_issue": "No", 
                "time_frame": "Baseline, two weeks, and four weeks"
            }
        ], 
        "source": "Brigham and Women's Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Brigham and Women's Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2014", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}